Eponemycin is a Streptomyces metabolite that blocks angiogenesis. Despite the potential of this anti-angiogenic agent for inhibiting tumor cell metastasis, little is known about its mechanism of action. The goal of the proposed studies is to elucidate the mechanism by which eponemycins exerts its angiostatic activity, and it is anticipated that these studies will lead to an increased understanding of angiogenesis. As the first step toward achieving this goal, a biotinylated eponemycin analog will be synthesized as a probe for the eponemycin binding proteins (EBPs). This analog will be used to isolate EBPs, presumably through covalent modification of its protein targets. EBPs will be cloned and systems to produce these proteins for structure and function studies will be developed. In addition, antibodies against the EBPs will be raised for western blot analysis and subcellular localization experiments. These antibodies will be used as reagents to explore the role of eponemycin in the cell cycle regulation. Specifically, EBP levels at different stages of the cell cycle will be monitored and the effect of anti-EBP on cell cycle progression will be examined. In addition, the gene encoding EBP will be transiently expressed in endothelial cells to analyze the effect of the protein on cell cycle progression. Other studies of the EBPs include examination of their phosphorylation state and, if the protein(s) are phosphorylated, identification of phosphorylated sites. To further characterize the role of EBPs, a library of anti-angiogenic ligands will be generated based on the predicted eponemycin pharmacophore.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA074967-03
Application #
2896058
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Fu, Yali
Project Start
1997-09-09
Project End
2000-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Yale University
Department
Physiology
Type
Schools of Arts and Sciences
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Crews, C M; Mohan, R (2000) Small-molecule inhibitors of the cell cycle. Curr Opin Chem Biol 4:47-53
Meng, L; Kwok, B H; Sin, N et al. (1999) Eponemycin exerts its antitumor effect through the inhibition of proteasome function. Cancer Res 59:2798-801
Crews, C M; Splittgerber, U (1999) Chemical genetics: exploring and controlling cellular processes with chemical probes. Trends Biochem Sci 24:317-20
Sin, N; Kim, K B; Elofsson, M et al. (1999) Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology. Bioorg Med Chem Lett 9:2283-8
Meng, L; Mohan, R; Kwok, B H et al. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A 96:10403-8
Elofsson, M; Splittgerber, U; Myung, J et al. (1999) Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones. Chem Biol 6:811-22
Kim, K B; Myung, J; Sin, N et al. (1999) Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: insights into specificity and potency. Bioorg Med Chem Lett 9:3335-40
Sin, N; Meng, L; Auth, H et al. (1998) Eponemycin analogues: syntheses and use as probes of angiogenesis. Bioorg Med Chem 6:1209-17